149587-85-9 Usage
General Description
2-Amino-5-isopropyl-thiophene-3-carboxylic acid methyl ester is a chemical compound with the molecular formula C10H15NO2S. It is a methyl ester derivative of 2-amino-5-isopropyl-thiophene-3-carboxylic acid and is commonly used in organic synthesis and pharmaceutical research. 2-AMINO-5-ISOPROPYL-THIOPHENE-3-CARBOXYLIC ACID METHYL ESTER has potential applications in the development of new drugs and medications, particularly in the treatment of certain neurological and psychiatric disorders. It is also used as a building block in the synthesis of various heterocyclic compounds with potential biological activities. Additionally, it has been studied for its potential antimicrobial and anticancer properties, making it a versatile and valuable chemical in the field of medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 149587-85-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,5,8 and 7 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 149587-85:
(8*1)+(7*4)+(6*9)+(5*5)+(4*8)+(3*7)+(2*8)+(1*5)=189
189 % 10 = 9
So 149587-85-9 is a valid CAS Registry Number.
149587-85-9Relevant articles and documents
Microwave-assisted synthesis of 2-aminothiophene derivatives via improved gewald reactions
Ruan, Bankang,Zhang, Zhiyan,Huang, Lei,Xu, Chao,Li, Luolan
, p. 2007 - 2018 (2021/09/29)
In this paper, a new and efficient method was developed to prepare 2-aminothiophene derivatives through improved Gewald reaction. Thirty-one final products were synthesized under microwave radiation for 30 min with 57%-95% isolated yields. All the product
THIENO [2,3-D] PYRIMIDINE COMPOUNDS AS INHIBITORS OF ADP-MEDIATED PLATELETS AGGREGATION
-
Page/Page column 95, (2008/06/13)
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I): wherein A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2, R4, R5, and R6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
